A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma

F Morschhauser, JF Seymour, HC Kluin-Nelemans, A Grigg, M Wolf, M Pfreundschuh, H Tilly, J Raemaekers, MB van 't Veer, N Milpied, G Cartron, A Pezzutto, A Spencer, F Reyes, M Dreyling